SUVEN LIFE SCIENCES LTD. - 530239 - Clarification On Volume Movement
Clarification on volume movement03-01-2024
SUVEN LIFE SCIENCES LTD. - 530239 - Clarification On Volume Movement
Clarification on volume movementSUVEN LIFE SCIENCES LTD. - 530239 - Closure of Trading Window
Intimation of closure of Trading windowSUVEN LIFE SCIENCES LTD. - 530239 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Neawspaper advertisement regarding reminder to claim the dividends remaining unpaid/ unclaimed and transfer of unclaimed equity shares of the company to the IEPF Authority.SUVEN LIFE SCIENCES LTD. - 530239 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report
Report of Monitoring Agency with respect to utilization of proceeds of the Rights Issue for the quarter ended 30th September 2023.SUVEN LIFE SCIENCES LTD. - 530239 - Announcement under Regulation 30 (LODR)-Newspaper Publication
News paper advertisement - Unaudited Financial Results of the company for the quarter and half year ended 30th September 2023SUVEN LIFE SCIENCES LTD. - 530239 - Statement Of Deviation For The Quarter Ended 30Th September 2023.
There were no deviation or variation in the use of proceeds from the objects for which funds were raised through the Rights Issue made by the company for the quarter ended 30th September 2023.SUVEN LIFE SCIENCES LTD. - 530239 - Unaudited Standalone And Consolidated Financial Results Of The Company Under Ind AS Along With Review Reports Of The Statutory Auditors For The Quarter And Half Year Ended September 30, 2023
Enclosed Unaudited standalone and consolidated financial results of the Company for the quarter and half year ended September 30, 2023SUVEN LIFE SCIENCES LTD. - 530239 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Please find attached News Relase of our Company.SUVEN LIFE SCIENCES LTD. - 530239 - Board Meeting Intimation for Board Meeting Of The Company To Be Held On Saturday, November 04, 2023
SUVEN LIFE SCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2023 ,inter alia, to consider and approve Un-audited Financial Results (Standalone and Consolidated) of the Company under Ind AS for the quarter and half year ended September 30, 2023 and related mattersSUVEN LIFE SCIENCES LTD. - 530239 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate in terms of Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter and half year ended 30th September 2023